Skip to content
A
  • HomeHome
  • SearchSearch
  • AskAsk
  • SavedSaved
  • IntelligenceIntelligence

Mucpharm

Organisation

Trials

  • NCT05258682

    Phase 1/2Status unknown202230 people28 Feb 2022clinicaltrials.gov

  • NCT03976973

    Phase 2Status unknown202262 people6 Jun 2019clinicaltrials.gov

  • News
  • Trials
  • Topics
  • Evidence
  • Conferences
  • Stats
  • Updates
  • API
  • Pricing

© 2026 AgingResearch.News

PrivacyTermsContact

    News

    See all →

    Longevica finds over sixty life-extending compounds in four-year mouse screen

    CompanyLongevity.Technology

    Immune aging accelerates near ages 40 and 60

    ResearchFuturity

    Direct AMPK activation modestly lengthens lifespan in short-lived species

    ResearchFight Aging!

    A protein complex with a bound molecule sits beside an unbound complex, with slightly more intact cells beneath the bound form and more fragments beneath the…

    Trials

    See all →

    Registered6 Oct 2026

    AKG and Brain Health in Aging

    Phase 2 · University of Oklahoma

    Registered2 Oct 2026

    Safety and Preliminary Efficacy of Adipose-Derived Stem Cell Secretome in Frailty (VinVital)

    Phase 1 · Vinmec Research Institute of Stem Cell and Gene Technology

    Registered7 Oct 2026

    AI-Based Conversational Social Support for Older Adults With Heart Failure

    Chang Gung University of Science and Technology

    Trending

    Evidence →
    1. Intervention · 66 papersExercise
    2. Gene · 24 papersAPOE
    3. Disease · 125 papersCardiovascular disease
    4. Process · 120 papersInflammation
    5. Biomarker · 46 papersBody mass index
    6. Intervention · 44 papersSmoking

    Topics

    See all →
    • Mechanisms293
    • Interventions412
    • Biomarkers387
    • Populations562
    • AI & data144
    • Industry & policy28
    • Conferences
    • Stats
    • Updates
    • API
    • Pricing
    • Privacy
    • Terms
    • Contact
    • © 2026 AgingResearch.News